Mycoplasma pneumonia in the elderly
Mycoplasma pneumonia is an acute respiratory infection with pneumonia caused by Mycoplasma pneumoniae. Mycoplasma pneumoniae is between viruses and bacteria. It can grow on cell-free culture medium, has no cell wall, contains RNA and DNA, and produces energy through metabolism. It is often confused with the L-type of bacteria, and the colonies of the two are similar. Mycoplasma is the pathogen of many animal diseases. Currently, there are 8 known human mycoplasmas, and only Mycoplasma pneumoniae can cause respiratory infections. It can ferment glucose and produce hemolysin, which can completely dissolve the red blood cells of sheep and guinea pigs within 24 to 48 hours, and can be distinguished from other mycoplasmas. Other mycoplasmas can cause urogenital system infections, generally without invading the respiratory tract. Mycoplasma pneumoniae often causes upper respiratory tract infections without pneumonia, and can also cause asymptomatic infections. Reports at home and abroad have shown that the incidence of mycoplasma pneumonia has a significant upward trend in recent years.
-
Site of disease:
lung -
Infectious :
Not contagious -
Frequent population:
Elderly -
Related symptoms:
Fatigue loss of appetite loss of appetite chest pain nasal congestion -
Concurrent disease:
Related Drugs
Roxithromycin Capsules
Indication: This product is suitable for pharyngitis and tonsillitis caused by Streptococcus pyogenes, sinusitis, otitis media, acute bronchitis, acute exacerbation of chronic bronchitis caused by sensitive bacteria, pneumonia caused by Mycoplasma pneumoniae or Chlamydia pneumoniae; urethritis and cervicitis caused by Chlamydia trachomatis; skin and soft tissue infections caused by sensitive bacteria.
Manufacturer:
Hubei Heng'an Fulin Pharmaceutical Co., Ltd.
Azithromycin for injection
Indication: This product is suitable for the following infections caused by sensitive pathogenic strains. 1 Community-acquired pneumonia caused by Chlamydia pneumoniae, Haemophilus influenzae, Legionella pneumophila, Moraxella catarrhalis, Mycoplasma pneumoniae, Staphylococcus aureus or Streptococcus pneumoniae that requires intravenous drip treatment first. 2 Pelvic inflammatory disease caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis that requires intravenous drip treatment first.
Manufacturer:
Hangzhou Ausia Biological Technology Co., Ltd.
Cefepime Hydrochloride for Injection
Indication: This product can be used to treat moderate to severe infections caused by the above-mentioned sensitive bacteria in adults and children aged 2 months to 16 years, including lower respiratory tract infections (pneumonia and bronchitis), simple lower urinary tract infections and complicated urinary tract infections (including pyelonephritis), uncomplicated skin and skin and soft tissue infections, complicated intra-abdominal infections (including peritonitis and biliary tract infections), obstetrics and gynecology infections, sepsis, and empirical treatment of patients with neutropenia and fever. It can also be used for bacterial cerebrospinal meningitis in children. Bacterial culture and drug sensitivity testing should be performed when bacterial infection is suspected, but because cefepime is a broad-spectrum bactericidal agent for Gram-positive and Gram-negative bacteria, cefepime monotherapy can be started before the results of drug sensitivity tests are known. When mixed anaerobic infections are suspected, it is recommended to use other anti-anaerobic drugs in combination.
Manufacturer:
STAR Pharmaceutical Pte.ltd
Related Ingredients